Search tips
Search criteria 


Logo of skullbasesurgInstructions for AuthorsSubscribe to Skull BaseAbout Skull BaseEditorial BoardThieme Medical PublishingSkull Base An Interdisciplinary Approach ...
Skull base surgery. 1994 January; 4(1): 46–51.
PMCID: PMC1656463

Pituitary Carcinoma


The presence of distant metastases may be asymptomatic in patients who present with symptoms and signs due to the local mass effects of an invasive pituitary adenoma. A case of pituitary carcinoma in a 54-year-old man who presented with widespread asymptomatic distant metastases 12 years after initial diagnosis is reviewed. The long course and asymptomatic metastases suggested a relatively slow-growing malignancy. The factors that played a role in the pathogenesis of the metastasis are unknown. A review of the literature on pituitary carcinoma suggests that accurate diagnosis and a multidisciplinary approach to management of such lesions emphasizing surgery, radiotherapy, and hormonal manipulation may provide these patients with the longest and best quality of survival.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mountcastle RB, Roof BS, Mayfield RK, Mordes DB, Sagel J, Biggs PJ, Rawe SE. Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci. 1989 Aug;298(2):109–118. [PubMed]
  • Asai A, Matsutani M, Funada N, Takakura K. Malignant growth hormone-secreting pituitary adenoma with hematogenous dural metastasis: case report. Neurosurgery. 1988 Jun;22(6 Pt 1):1091–1094. [PubMed]
  • Cohen DL, Diengdoh JV, Thomas DG, Himsworth RL. An intracranial metastasis from a PRL secreting pituitary tumour. Clin Endocrinol (Oxf) 1983 Mar;18(3):259–264. [PubMed]
  • GRAF CJ, BLINDERMAN EE, TERPLAN KL. Pituitary carcinoma in a child with distant metastases. J Neurosurg. 1962 Mar;19:254–259. [PubMed]
  • Hashimoto N, Handa H, Nishi S. Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumor. Case report. J Neurosurg. 1986 Jan;64(1):140–144. [PubMed]
  • Kuroki M, Tanaka R, Yokoyama M, Shimbo Y, Ikuta F. Subarachnoid dissemination of a pituitary adenoma. Surg Neurol. 1987 Jul;28(1):71–76. [PubMed]
  • Nudleman KL, Choi B, Kusske JA. Primary pituitary carcinoma: a clinical pathological study. Neurosurgery. 1985 Jan;16(1):90–95. [PubMed]
  • Plangger CA, Twerdy K, Grunert V, Weiser G. Subarachnoid metastases from a prolactinoma. Neurochirurgia (Stuttg) 1985 Nov;28(6):235–237. [PubMed]
  • U HS, Johnson C. Metastatic prolactin-secreting pituitary adenoma. Hum Pathol. 1984 Jan;15(1):94–96. [PubMed]
  • Nawata H, Higuchi K, Ikuyama S, Kato K, Ibayashi H, Mimura K, Sueishi K, Zingami H, Imura H. Corticotropin-releasing hormone- and adrenocorticotropin-producing pituitary carcinoma with metastases to the liver and lung in a patient with Cushing's disease. J Clin Endocrinol Metab. 1990 Oct;71(4):1068–1073. [PubMed]
  • Popovic EA, Vattuone JR, Siu KH, Busmanis I, Pullar MJ, Dowling J. Malignant prolactinomas. Neurosurgery. 1991 Jul;29(1):127–130. [PubMed]
  • Landolt AM. Ultrastructure of human sella tumors. Correlations of clinical findings and morphology. Acta Neurochir (Wien) 1975;Suppl 22:1–167. [PubMed]
  • Jefferson G. Extrasellar Extensions of Pituitary Adenomas: (Section of Neurology). Proc R Soc Med. 1940 May;33(7):433–458. [PMC free article] [PubMed]
  • Sautner D, Saeger W. Invasiveness of pituitary adenomas. Pathol Res Pract. 1991 Jun;187(5):632–636. [PubMed]
  • Ogilvy KM, Jakubowski J. Intracranial dissemination of pituitary adenomas. J Neurol Neurosurg Psychiatry. 1973 Apr;36(2):199–205. [PMC free article] [PubMed]
  • Nelson PB, Robinson AG, Martinez AJ. Metastatic tumor of the pituitary gland. Neurosurgery. 1987 Dec;21(6):941–944. [PubMed]
  • Chiang MF, Brock M, Patt S. Pituitary metastases. Neurochirurgia (Stuttg) 1990 Jul;33(4):127–131. [PubMed]
  • Post KD, McCormick PC, Hays AP, Kandji AG. Metastatic carcinoma to pituitary adenoma. Report of two cases. Surg Neurol. 1988 Oct;30(4):286–292. [PubMed]
  • James RL, Jr, Arsenis G, Stoler M, Nelson C, Baran D. Hypophyseal metastatic renal cell carcinoma and pituitary adenoma. Case report and review of the literature. Am J Med. 1984 Feb;76(2):337–340. [PubMed]
  • Tubiana M, Pejovic MH, Koscielny S, Chavaudra N, Malaise E. Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer. 1989 Jul 15;44(1):17–22. [PubMed]
  • Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg. 1989 Mar;70(3):379–384. [PubMed]
  • Hsu DW, Hakim F, Biller BM, de la Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg. 1993 May;78(5):753–761. [PubMed]
  • Ciric I, Mikhael M, Stafford T, Lawson L, Garces R. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg. 1983 Sep;59(3):395–401. [PubMed]
  • Flickinger JC, Nelson PB, Martinez AJ, Deutsch M, Taylor F. Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer. 1989 Jun 15;63(12):2409–2414. [PubMed]
  • Grigsby PW, Simpson JR, Fineberg B. Late regrowth of pituitary adenomas after irradiation and/or surgery. Hazard function analysis. Cancer. 1989 Apr 1;63(7):1308–1312. [PubMed]
  • Konopka P, Raymond JP, Merceron RE, Seneze J. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol. 1983 Aug 15;146(8):935–938. [PubMed]
  • Maurer RA. Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem. 1980 Sep 10;255(17):8092–8097. [PubMed]
  • Weiss MH, Wycoff RR, Yadley R, Gott P, Feldon S. Bromocriptine treatment of prolactin-secreting tumors: surgical implications. Neurosurgery. 1983 Jun;12(6):640–642. [PubMed]
  • Mori H, Maeda T, Saitoh Y, Onishi T. Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine. Pathol Res Pract. 1988 Sep;183(5):580–583. [PubMed]
  • Scheithauer BW, Randall RV, Laws ER, Jr, Kovacs KT, Horvath E, Whitaker MD. Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer. 1985 Feb 1;55(3):598–604. [PubMed]
  • Melmed S, Braunstein GD, Chang RJ, Becker DP. Pituitary tumors secreting growth hormone and prolactin. Ann Intern Med. 1986 Aug;105(2):238–253. [PubMed]
  • Wollesen F, Andersen T, Karle A. Size reduction of extrasellar pituitary tumors during bromocriptine treatment. Ann Intern Med. 1982 Mar;96(3):281–286. [PubMed]
  • Salti IS, Istfan N. Bromocriptine fails to stop growth of eosinophilic adenomas in acromegaly. N Engl J Med. 1979 Aug 16;301(7):386–386. [PubMed]
  • Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 1988 Jan;66(1):16–23. [PubMed]
  • Lamberts SW, Uitterlinden P, del Pozo E. SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years. J Clin Endocrinol Metab. 1987 Oct;65(4):703–710. [PubMed]

Articles from Skull Base Surgery are provided here courtesy of Thieme Medical Publishers